Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC
Clinical trial NCT05720260 · RECRUITING
Trial details
- NCT number
- NCT05720260
- Sponsor
- National Taiwan University Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-17
- Primary completion
- 2024-12-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.